AnaMar Medical AB - Product Pipeline Review - Q4 2010

Global Markets Direct, December 2010, Pages: 28

AnaMar Medical AB – Product Pipeline Review - Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “AnaMar Medical AB - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- AnaMar Medical AB - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of AnaMar Medical AB human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of AnaMar Medical AB with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the AnaMar Medical AB’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate AnaMar Medical AB’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of AnaMar Medical AB in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the AnaMar Medical AB’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with AnaMar Medical AB.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of AnaMar Medical AB and identify potential opportunities in those areas.

List of Tables
List of Figures
AnaMar Medical AB Snapshot
AnaMar Medical AB Overview
Key Information
Key Facts
AnaMar Medical AB – Research and Development Overview
Key Therapeutic Areas
AnaMar Medical AB – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
AnaMar Medical AB – Pipeline Products Glance
AnaMar Medical AB Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
AnaMar Medical AB–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
AnaMar Medical AB – Drug Profiles
AMAP102
Product Description
Mechanism of Action
R&D Progress
AM260 TASS
Product Description
Mechanism of Action
R&D Progress
ColMod
Product Description
Mechanism of Action
R&D Progress
SCI
Product Description
Mechanism of Action
R&D Progress
DAR
Product Description
Mechanism of Action
R&D Progress
AnaMar Medical AB – Pipeline Analysis
AnaMar Medical AB – Pipeline Products by Therapeutic Class
AnaMar Medical AB Pipeline Products By Target
AnaMar Medical AB – Pipeline Products by Route of Administration
AnaMar Medical AB – Pipeline Products by Molecule Type
AnaMar Medical AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
AnaMar Medical AB, Deals Summary, 2004 to 2010
AnaMar Medical AB Detailed Deal Summary
Venture Financing
AnaMar Medical Secures $7.3 Million In Financing
Anamar Secures $7.06 Million In Venture Financing
Equity Offering
AnaMar Medical Completes Private Placement Of $9.58 Million
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• Aerospace and Defense Industry - Global Strategic Business Report
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• eLEARNING - Global Strategic Business Report
• The Sweden Defense Industry - Competitive Landscape and Strategic Insights to 2017: Market Profile
• Charter Schools - Global Outlook
• Aerospace and Defence Industry - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Military Ground Robot Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
• Aerospace and Defense Report 2011